CPG
AGRX

Cornerstone Planning Group’s Agile Therapeutics AGRX Stock Holding History

Cornerstone Planning Group’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed -$20 – 1205
2023
Q4 		$20 Hold
10
– – ﹤0.01% 940
2023
Q3 		$24 Hold
10
– – ﹤0.01% 1171
2023
Q2 		$30 Buy
+10
New +$53 ﹤0.01% 1560
2022
Q4 		$141 Buy
+10
New +$116 ﹤0.01% 1523

Other funds holding AGRX

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Cornerstone Planning Group's AGRX Position: Q1 2024 in Review

Cornerstone Planning Group sold out of Agile Therapeutics (AGRX) in Q1 2024, closing a stake of 10 shares — an estimated $20 sold.

Cornerstone Planning Group first reported a position in AGRX in Q4 2022 and held it in 4 quarters. The position peaked at $141 in Q4 2022. 1 fund tracked by Wall St. Rank holds AGRX as of Q1 2024.

  • Cornerstone Planning Group reported no remaining Agile Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cornerstone Planning Group sold 10 Agile Therapeutics shares in Q1 2024, an estimated $20.
  • Cornerstone Planning Group first reported a position in Agile Therapeutics in Q4 2022 and held it in 4 quarters.
  • Cornerstone Planning Group's Agile Therapeutics position peaked at $141 in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Agile Therapeutics as of Q1 2024.

Based on Cornerstone Planning Group's 13F filing for Q1 2024, filed 7 May 2024.